Tag: Cancer: Prostate
Many Low-Risk Prostate Cancer Cases Upgraded at Prostatectomy
Upgrading, up staging linked to age >60, PSA >5.0 ng/ml, and >25 percent positive cores
More Radiation Doesn’t Up Survival in Low-Risk Prostate CA
But higher doses may improve survival in men with intermediate- and high-risk prostate cancers
Surveillance Becoming More Common for Prostate Cancer
Many men with low-risk disease being spared prostatectomy, radiation, androgen deprivation tx
Too Few Prostate Cancer Patients Receiving Active Surveillance
Researchers find 12 percent or fewer U.S. men with low-risk prostate cancer getting active surveillance
Age-Adjusted Comorbidity Score Stratifies Mortality in Prostate CA
Age-adjusted prostate cancer-specific comorbidity index strongly predictive of other-cause mortality
Metabolic Syndrome Up With ADT in Prostate Cancer
Increases in components of metabolic syndrome, and in prevalence of full metabolic syndrome
Primary Androgen Deprivation Tx May Raise DM Risk by 60 Percent
Findings among men treated for localized prostate cancer
AUA: PCPs Embracing New PSA Recommendations
Primary care screening patterns have changed as a result of the USPSTF recommendation
ASCO: Docetaxel With Hormone Tx May Improve Outcomes
Combination with hormone therapy can extend life by almost a year for prostate cancer patients
ADT for Prostate Cancer Tied to Impaired Cognition
Men with a particular gene mutation affected most, researchers find
